Philip W. Howard
- Oncology
- Radiology, Nuclear Medicine and Imaging top 10%
- Molecular Biology
- Organic Chemistry
- Immunology
- Co-authors
- John A. HartleyDavid G. WilliamsKerry ChesterJohn R. AdairFrancesca ZammarchiArnaud TiberghienDavid E. ThurstonElizabeth Murray
- Topics
- HER2/EGFR in Cancer Research (8 papers)Monoclonal and Polyclonal Antibodies Research (6 papers)Cancer therapeutics and mechanisms (5 papers)
- Partner nations
- United KingdomMexicoBrazil
In The Last Decade
Philip W. Howard
15 papers receiving 208 citations
Peers
Comparison fields: 5 of 41
- Oncology 129
- Radiology, Nuclear Medicine and Imaging 112
- Molecular Biology 83
- Organic Chemistry 37
- Immunology 33
Countries citing papers authored by Philip W. Howard
This map shows the geographic impact of Philip W. Howard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip W. Howard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip W. Howard more than expected).
Fields of papers citing papers by Philip W. Howard
This network shows the impact of papers produced by Philip W. Howard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip W. Howard. The network helps show where Philip W. Howard may publish in the future.
Co-authorship network of co-authors of Philip W. Howard
This figure shows the co-authorship network connecting the top 25 collaborators of Philip W. Howard. A scholar is included among the top collaborators of Philip W. Howard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip W. Howard. Philip W. Howard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 37 | |
| 3 | 12 | |
| 4 | 6 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 9 | |
| 8 | 4 | |
| 9 | 17 | |
| 10 | 12 | |
| 11 | 5 | |
| 12 | 1 | |
| 13 | 91 | |
| 14 | 9 | |
| 15 | 8 |
About Philip W. Howard
Philip W. Howard is a scholar working on Oncology, Immunology and Allergy and Radiology, Nuclear Medicine and Imaging, having authored 15 papers that have together received 214 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Cancer therapeutics and mechanisms (5 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (112 citations), Oncology (129 citations) and Immunology and Allergy (24 citations). Philip W. Howard has collaborated with scholars based in United Kingdom, Mexico and Brazil. Frequent co-authors include John A. Hartley, David G. Williams, Kerry Chester, John R. Adair, Francesca Zammarchi, Arnaud Tiberghien, David E. Thurston, Elizabeth Murray, Patrick H. van Berkel and Nicholas F. Brown. Their work appears in journals such as Blood, Cancer Research and The Journal of Organic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.